Dren Bio

San Carlos, United States · Founded 2019 · $1.8B raised

Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$1.8B
Last Round
$1.7B Corporate RoundDec 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Dren Bio is a San Carlos, California-based clinical-stage biopharmaceutical company pioneering antibody therapeutics that deplete pathogenic cells and agents. Founded in May 2019 by CEO Nenad Tomasevic, the company develops bispecific antibodies that selectively engage effector cells to treat cancer and autoimmune diseases. In 2025, Sanofi agreed to acquire Dren Bio's lead CD20-directed bispecific antibody program DR-0201.

Summary

Dren Bio is a Biotech company based in San Carlos, United States, founded in 2019. It has raised $1.8B in total across 4 rounds, most recently a $1.7B Corporate Round in Dec 2025. Investors include 8VC, Sanofi Ventures and Pfizer Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundDec 2025
$1.7B

Sign up to see all 4 events

Funding: Seed through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Dren Bio on Indexed.vc
<a href="https://indexed.vc/companies/dren-bio"><img src="https://indexed.vc/api/badge/company/dren-bio" alt="Dren Bio on Indexed.vc" width="260" height="76" /></a>